Gemcitabin Hikma 38 mg/ml Konzentrat zur Herstellung einer Infusionslösung clinical trials

A Randomized, Double-Blind, Placebo-Controlled Study of Nab-Paclitaxel and Gemcitabine With Or Without SBP-101 in Subjects Previously Untreated for Metastatic Pancreatic Ductal Adenocarcinoma

This study is testing a new drug, SBP-101, alongside standard treatments (Nab-paclitaxel and Gemcitabine) for advanced pancreatic cancer that hasn't been treated before. Researchers want to see if adding SBP-101 helps people live longer.